Recall of and Reactions to a Surgeon Referral Letter for BRCA Genetic Counseling Among High-Risk Breast Cancer Patients
- 30 April 2009
- journal article
- Published by Springer Science and Business Media LLC in Annals of Surgical Oncology
- Vol. 16 (7), 1973-1981
- https://doi.org/10.1245/s10434-009-0479-4
Abstract
The oncology care setting represents an important opportunity to identify and refer women at increased risk for hereditary breast and ovarian cancer. However, little is known about the effectiveness of provider approaches to inform patients of hereditary cancer risk or patient uptake of genetic counseling (GC). This qualitative study examined the impact of a surgeon referral letter on recently diagnosed breast cancer patients' uptake of BRCA GC. Qualitative open-ended, in-depth interviews were conducted with 26 high-risk breast cancer patients sent a referral letter for BRCA GC by their surgeon. Data were analyzed by a grounded theory approach. Most women (approximately 80%) recalled receiving the letter, and 62% of all (n = 16) women pursued GC. Recall of the letter did not seem to be associated with uptake of GC (P = .49, Fisher's exact test). The results highlight key areas for improvement that may help increase the impact of the letter. Half of the women in this sample believed that the letter was sent to all breast cancer patients, rather than those with specific risk factors. Few women mentioned any implications for the information obtained during GC or testing regarding their current breast cancer diagnosis or treatment. Of the women who did not attend, many perceived that dealing with the GC and testing process in the midst of a cancer diagnosis and treatment was overwhelming. Among the women who had chosen not to attend GC, most stated they would reconsider after completing their treatment. Patient recall of a surgeon referral letter does not seem to increase the number of high-risk women who attend GC after a breast cancer diagnosis. The letter approach in its current format does not seem to be a wholly effective means of communicating with some patients who may be overwhelmed by their cancer diagnosis or unaware that GC and testing may have implications for their current treatment decisions, possibly resulting in a missed opportunity to engage in informed decision making.Keywords
This publication has 22 references indexed in Scilit:
- Increasing Utilization of Cancer Genetic Counseling Services Using a Patient Navigator ModelJournal of Genetic Counseling, 2007
- Referral and Experience with Genetic Testing Among Women with Early Onset Breast CancerGenetic Testing, 2005
- Initial cancer genetic counseling consultation: Change in counselees' cognitions and anxiety, and association with addressing their needs and preferencesAmerican Journal of Medical Genetics Part A, 2005
- Utilization of BRCA1/BRCA2 Mutation Testing in Newly Diagnosed Breast Cancer PatientsCancer Epidemiology, Biomarkers & Prevention, 2005
- Impact of BRCA1/BRCA2 Counseling and Testing on Newly Diagnosed Breast Cancer PatientsJournal of Clinical Oncology, 2004
- Effect of Genetic Cancer Risk Assessment on Surgical Decisions at Breast Cancer DiagnosisArchives of Surgery, 2003
- What Does My Doctor Think? Preferences for Knowing the Doctor's Opinion Among Women Considering Clinical Testing for BRCA1/2 MutationsGenetic Testing, 2002
- Identification and Referral of Families at High Risk for Cancer SusceptibilityJournal of Clinical Oncology, 2002
- Factors Influencing Patients' Decisions to Decline Cancer Genetic Counseling ServicesJournal of Genetic Counseling, 2001
- Efficacy of a touchscreen computer based family cancer history questionnaire and subsequent cancer risk assessmentJournal of Medical Genetics, 2000